Middle East Africa Group

Middle East Africa Group (MEAG) is a prominent healthcare service provider and commercialization partner specializing in the Middle East and Africa (MEA) markets. The company serves as a strategic bridge for global biotechnology and pharmaceutical firms, providing a comprehensive range of services including regulatory affairs, market access, medical affairs, and specialized logistics. MEAG focuses heavily on high-value therapeutic areas such as oncology, neurology, and rare diseases, managing the regional distribution and promotion of innovative therapies for partners like Biogen, Gilead Sciences, and Amgen. Headquartered in Dubai, the company is instrumental in navigating the complex regulatory and commercial landscapes of the MENA region to deliver specialty medicines to patients.